MAPT and Alzheimer disease: The last one, along with neuroinflammation, oxidative stress, increased levels of advanced glycosylation end products, mitochondrial dysfunction, metabolic syndrome, and the accumulation of Aβ and tau protein in the brain, are common features of AD and DM2 (reviewed in [14]).